Neocyte

Neocyte Warnings

filgrastim

Manufacturer:

UNILAB, Inc

Distributor:

UNILAB, Inc
Full Prescribing Info
Warnings
Splenic rupture, including fatal cases, has been reported following the administration of rhG-CSF. Individuals receiving rhG-CSF should report left abdominal and/or shoulder tip pain should be evaluated for enlarged spleen or splenic rupture.
Severe sickle cell crises, in some cases resulting in death, have been associated with the use of rhG-CSF in patients with sickle cell disorders. Only physicians qualified by specialized training or experience in the treatment of patients with sickle cell disorders should prescribe rhG-CSF for such patients, and only after careful consideration of the potential risks and benefit
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in